日光性痒疹患儿接受巴瑞替尼治疗获得成功：病例报告。
Successful treatment of actinic prurigo with baricitinib in an 8-year-old child: A case report.
机构信息
Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Pediatr Dermatol. 2024 Nov-Dec;41(6):1159-1161. doi: 10.1111/pde.15643. Epub 2024 Apr 29.
PMID:38684232
Abstract
Actinic prurigo is a rare photodermatosis characterized by pruritic papulonodular lesions. Treatment is challenging, especially in children, as sun protection strategies need to be rigorously implemented and symptoms often persist throughout the year. Herein, we present a case of actinic prurigo in an 8-year-old patient with rapid and successful relief with baricitinib.
摘要
光化性痒疹是一种罕见的光致皮肤病，其特征是瘙痒性丘疹结节性病变。治疗具有挑战性，尤其是在儿童中，因为需要严格实施防晒策略，并且症状通常全年持续存在。在此，我们报告了一例 8 岁患者的光化性痒疹病例，巴瑞替尼治疗起效迅速且疗效显著。
Zotero 插件